Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

HIV therapy success rates similar in developing and developed world, study shows

01.08.2005


A new study from the University of Alberta reveals that people with HIV in developing countries do just as well on antiretroviral therapy (ART) programs as do people with HIV on ART programs in developed countries. It also shows that people with HIV who are given free ART drugs will do "significantly" better at fighting the disease compared to those who must pay for the drugs.



"ART programs are complex therapeutic regimens that require patients to take a minimum of three pills a day for the rest of their lives," said Dr. Karen Doucette, a professor in the U of A Division of Infectious Diseases. "It’s often difficult for people in North America to maintain the regimens, so some critics believe these programs can’t work in resource poor settings, where patients don’t have the support--the pharmacists, the social workers, and the physicians, for example--that we have."

However, after reviewing more than 100 research papers on the topic, Doucette and her colleagues concluded ART programs have the same efficacy rates in both developed and non-developed countries. The general success rate in keeping the virus suppressed after being on the program for 12 to 18 months is about 60 per cent. The results are published this month in the journal Clinical Infectious Diseases.


Doucette said she was not surprised with the results, except for the fact that people in developing countries who received free ART drugs did so much better--30 per cent higher rates of success--than people who had to pay for their drugs.

"Although this intuitively makes sense, it was a satisfying surprise to be able to demonstrate the impact of payment for ART on its success. This has important potential implications for ART program development, which is ongoing in many resource-poor settings around the world," Doucette said.

According to the latest numbers from the UN, about 40 million people currently have HIV. The vast majority of these people live in developing countries, with almost 75 per cent living in Sub-Saharan Africa. The UN’s goal is to provide at least 3 million people living with HIV/AIDS in low- and middle-income countries with ART by the end of 2005.

The number of people receiving ART has been increasing in every region in the world, with Sub-Saharan Africa doubling the number of people on ART to 500,000 in the past six months. As of June 2005, about 1 million people are on ART. Doucette believes these recent results are encouraging, but she says there must be ongoing political, financial and technical support to keep the trend going.

"Our study shows that there’s no reason why people in Africa and other resource-poor settings won’t follow ART regimens if they can access the treatments. We just have to make sure that everyone knows this and the support for these programs are strengthened over time," Doucette said.

Ryan Smith | EurekAlert!
Further information:
http://www.ualberta.ca

More articles from Studies and Analyses:

nachricht Real-time feedback helps save energy and water
08.02.2017 | Otto-Friedrich-Universität Bamberg

nachricht The Great Unknown: Risk-Taking Behavior in Adolescents
19.01.2017 | Max-Planck-Institut für Bildungsforschung

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Stingless bees have their nests protected by soldiers

24.02.2017 | Life Sciences

New risk factors for anxiety disorders

24.02.2017 | Life Sciences

MWC 2017: 5G Capital Berlin

24.02.2017 | Trade Fair News

VideoLinks
B2B-VideoLinks
More VideoLinks >>>